Tesla Cybercab Launch Puts Robotaxi Ambitions in Focus 
Anthropic Nears $15 Billion Credit Deal Ahead of IPO 
GSM Eyes US, Europe Expansion Ahead of 2028 Hong Kong IPO 
MongoDB Stock Sinks 14% as Atlas Growth Misses Expectations 
BP Names Ian Tyler Permanent Chairman After Governance Shake-Up 
Lenovo Shares Fall After Dropbox Security Breach Exposes ID Vulnerability 
Deutsche Telekom Shares Rise as Elliott Pushes Against T-Mobile Merger 
CATL Shares Fall as Hungary Plant Faces Safety Halt 
Audi, SAIC Launch China Innovation Hub for New AUDI Models 
SEC Seeks ISS Client Voting Records in Proxy Adviser Probe 
OpenAI Launches GPT-6 Astra With Advanced AI Agent Capabilities 
South Korea, US Discuss Chip Investments Amid Tariff Plans 
Berkshire Hathaway Eyes Bigger Stakes in Japan’s Top Trading Houses 
Honda Targets $9.4 Billion in Cost Cuts as China EV Competition Intensifies 
Tesla Cybercab Rides Launch in Austin as NHTSA Reviews Rollout 
Xiaomi Shares Jump on Europe EV Expansion Plan 
Add as a preferred source on Google
ANN ARBOR, Mich., Feb. 20, 2018 -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today announced its participation in the Bank of America Merrill Lynch Animal Health Summit on Monday, February 26, 2018, in New York, NY.
Chief Financial Officer Shameze Rampertab, CPA, CA, is part of a panel discussion on “Innovation in Companion Animal Therapeutics” at 8:40 a.m. E.T. and will be available to participate in one-on-one meetings to discuss Zomedica’s pipeline development and key milestones with investors registered to attend the conference.
About Zomedica
Based in Ann Arbor, Michigan, Zomedica (NYSE American:ZOM) (TSX-V:ZOM) is a veterinary diagnostic and pharmaceutical company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. Zomedica’s product portfolio will include novel diagnostics and innovative therapeutics that emphasize patient health and practice health. With a team that includes clinical veterinary professionals, it is Zomedica’s mission to give veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care. For more information, visit www.ZOMEDICA.com.
Follow Zomedica
- Email Alerts: http://investors.zomedica.com/
- LinkedIn: https://www.linkedin.com/company/zomedica
- Facebook: https://www.facebook.com/zomedica/
- Twitter: https://twitter.com/zomedica
Reader Advisory
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release.
Investor Relations Contact
Shameze Rampertab, CPA, CA
[email protected]
+1 647.283.3630
PCG Advisory Group
Kirin Smith, COO
[email protected]
+1 646.863.6519
www.pcgadvisory.com
Media Contact
Andrea Eberle
[email protected]
+1 734.369.2555
